Related references
Note: Only part of the references are listed.Risk factors for renal toxicity after inpatient cisplatin administration
Elena Galfetti et al.
BMC PHARMACOLOGY & TOXICOLOGY (2020)
Nephroprotective Effect of Cilastatin against Gentamicin-Induced Renal Injury In Vitro and In Vivo without Altering Its Bactericidal Efficiency
Juan Carlos Jado et al.
ANTIOXIDANTS (2020)
Cilastatin: a potential treatment strategy against COVID-19 that may decrease viral replication and protect from the cytokine storm
Maria Angeles Gonzalez-Nicolas et al.
CLINICAL KIDNEY JOURNAL (2020)
Recent Advances in Models, Mechanisms, Biomarkers, and Interventions in Cisplatin-Induced Acute Kidney Injury
Sara J. Holditch et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Hemodynamic goal-directed therapy and postoperative kidney injury: an updated meta-analysis with trial sequential analysis
Mariateresa Giglio et al.
CRITICAL CARE (2019)
Identification of risk factors associated with postoperative acute kidney injury after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a retrospective study
Juan P. Cata et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2018)
Causes of Death after a Hospitalization with AKI
Samuel A. Silver et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Identifying cisplatin-induced kidney damage in paediatric oncology patients
Chris D. Barton et al.
PEDIATRIC NEPHROLOGY (2018)
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
W. J. van Driel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Lipid imaging for visualizing cilastatin amelioration of cisplatin-induced nephrotoxicity
Estefania Moreno-Gordaliza et al.
JOURNAL OF LIPID RESEARCH (2018)
Acute kidney injury in ovarian cancer patients undergoing cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy
Eliza I-Lin Sin et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2017)
Megalin Blockade with Cilastatin Suppresses Drug-Induced Nephrotoxicity
Yoshihisa Hori et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Cisplatin-induced renal inflammation is ameliorated by cilastatin nephroprotection
Blanca Humanes et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity
Daniel J. Crona et al.
ONCOLOGIST (2017)
Association of Fluid Administration With Morbidity in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy
Oliver S. Eng et al.
JAMA SURGERY (2017)
Assessment of RIFLE and AKIN criteria to define acute renal dysfunction for HIPEC procedures for ovarian and non ovarian peritoneal malignances
A. Arjona-Sanchez et al.
EJSO (2016)
Hyperthermic intraperitoneal chemotherapy with cisplatin: Amifostine prevents acute severe renal impairment
N. Bouhadjari et al.
EJSO (2016)
Morbidity and mortality outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients aged 75 years and over: Spanish group of peritoneal cancer surgery (GECOP) multicenter study
P. A. Cascales-Campos et al.
SURGICAL ONCOLOGY-OXFORD (2016)
A Randomized Trial of Goal Directed vs Standard Fluid Therapy in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
Luca Colantonio et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2015)
Protective Effects of Cilastatin against Vancomycin-Induced Nephrotoxicity
Blanca Humanes et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Peritoneal Carcinomatosis from Colon Cancer: A Systematic Review of the Data for Cytoreduction and Intraperitoneal Chemotherapy
Ashlie Nadler et al.
CLINICS IN COLON AND RECTAL SURGERY (2015)
HIPEC ROC I: A phase I study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer
Oliver Zivanovic et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery
Hakeam A. Hakeam et al.
RENAL FAILURE (2014)
Complications and Toxicities After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Aras Emre Canda et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Pharmacokinetics of cisplatin during hyperthermic intraperitoneal treatment of peritoneal carcinomatosis
P. H. Cashin et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review
Jose Antonio Lopes et al.
CLINICAL KIDNEY JOURNAL (2013)
Interventions for protecting renal function in the perioperative period
Mathew Zacharias et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats
Blanca Humanes et al.
KIDNEY INTERNATIONAL (2012)
Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury
Ion D. Bucaloiu et al.
KIDNEY INTERNATIONAL (2012)
Elemental Bioimaging in Kidney by LA-ICP-MS As a Tool to Study Nephrotoxicity and Renal Protective Strategies in Cisplatin Therapies
Estefania Moreno-Gordaliza et al.
ANALYTICAL CHEMISTRY (2011)
Epidemiological Expansion, Structural Studies, and Clinical Challenges of New beta-Lactamases from Gram-Negative Bacteria
Karen Bush et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 65 (2011)
Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French Study
Dominique Elias et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cilastatin Attenuates Cisplatin-Induced Proximal Tubular Cell Damage
Sonia Camano et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Hyperthermic intraperitoneal chemotherapy: Rationale and technique
Santiago Gonzalez-Moreno et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2010)
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience
Tristan D. Yan et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Postoperative residual disease evaluation in the locoregional treatment of peritoneal surface malignancy
Santiago Gonzalez-Moreno et al.
JOURNAL OF SURGICAL ONCOLOGY (2008)
The intraoperative staging systems in the management of peritoneal surface malignancy
A. Gomez Portilla et al.
JOURNAL OF SURGICAL ONCOLOGY (2008)
Critical analysis of treatment failure after complete cytoreductive surgery and Perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms
Tristan D. Yan et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Cilastatin protection against cyclosporin A-induced nephrotoxicity: clinical evidence
A. Tejedor et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Acute renal disease, as defined by the RIFLE criteria, post-liver transplantation
A. O'Riordan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis
Eric A. J. Hoste et al.
CRITICAL CARE (2006)
Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels
DT Dickey et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Role of early plasma membrane events in chemotherapy-induced cell death
MT Dimanche-Boitrel et al.
DRUG RESISTANCE UPDATES (2005)
Inhibition of brush border dipeptidase with cilastatin reduces toxic accumulation of cyclosporin A in kidney proximal tubule epithelial cells
M Pérez et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
The effect of various chemotherapeutic agents given with mild hyperthermia on different types of tumours
M Takemoto et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2003)
Share Paper
